State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China.
Hum Gene Ther. 2010 Jun;21(6):728-38. doi: 10.1089/hum.2009.192.
The adeno-associated virus (AAV) p5 promoter controls expression of Rep68 and Rep78, which are responsible for specific integration of the viral genome into the AAVS1 site of the human genome. The p5 promoter contains a Rep-binding element (RBE) sequence that acts as a substrate of the Rep proteins for both site-specific integration of p5 itself and transcriptional suppression of the p5 promoter. To differentiate these two Rep-mediated functions, we dissected the p5 core structure TATA/RBE/YY1+1 through a series of mutations. Mutations in the TATA box or YY1+1 region of p5IEE significantly reduced Rep-mediated site-specific integration (RMSSI) and p5 promoter transcriptional activity, but only the TATA box is involved in Rep-mediated transcriptional suppression (RMTS). Point mutations at nucleotides 266, 267, 268, 270, and 273 of the GAGTGAGC motif in p5 RBE significantly reduced RMSSI efficiency. However, only p5G270T lost the affinity of Rep binding and had significant reduction of RMTS. It appears that RMTS is determined by the affinity of p5RBE for Rep whereas RMSSI requires more stringent conditions. Thus, RMTS and RMSSI can be differentiated by point mutations in the p5 promoter, which is useful in gene therapy in a helper vector to drive Rep expression, as the mutant promoters seldom integrate themselves but remain the RMTS feature for reduced cytotoxicity caused by a high level of Rep protein.
腺相关病毒 (AAV) p5 启动子控制 Rep68 和 Rep78 的表达,这两种蛋白负责病毒基因组特异性整合到人类基因组的 AAVS1 位点。p5 启动子包含一个 Rep 结合元件 (RBE) 序列,该序列是 Rep 蛋白特异性整合 p5 自身和 p5 启动子转录抑制的底物。为了区分这两种 Rep 介导的功能,我们通过一系列突变对 p5 核心结构 TATA/RBE/YY1+1 进行了剖析。p5IEE 中的 TATA 盒或 YY1+1 区突变显著降低了 Rep 介导的特异性整合 (RMSSI) 和 p5 启动子转录活性,但只有 TATA 盒参与 Rep 介导的转录抑制 (RMTS)。p5RBE 中 GAGTGAGC 基序的 266、267、268、270 和 273 位核苷酸的点突变显著降低了 RMSSI 效率。然而,只有 p5G270T 失去了 Rep 结合的亲和力,RMTS 显著降低。似乎 RMTS 由 p5RBE 与 Rep 的亲和力决定,而 RMSSI 需要更严格的条件。因此,p5 启动子的点突变可区分 RMTS 和 RMSSI,这在辅助载体驱动 Rep 表达的基因治疗中很有用,因为突变启动子很少自身整合,但仍保持 RMTS 特征,以降低高水平 Rep 蛋白引起的细胞毒性。